The crystal structure of lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function

Dihydroorotate dehydrogenases (DHODs) catalyze the oxidation of (S)‐dihydroorotate to orotate, the fourth step and only redox reaction in the de novo biosynthesis of pyrimidine nucleotides. A description is given of the crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A (DHODA) complexed with the product of the enzyme reaction orotate. The structure of the complex to 2.0 Å resolution has been compared with the structure of the native enzyme. The active site of DHODA is known to contain a water filled cavity buried beneath a highly conserved and flexible loop. In the complex the orotate displaces the water molecules from the active site and stacks above the DHODA flavin isoalloxazine ring, causing only small movements of the surrounding protein residues. The orotate is completely buried beneath the protein surface, and the orotate binding causes a significant reduction in the mobility of the active site loop. The orotate is bound by four conserved asparagine side chains (Asn 67, Asn 127, Asn 132, and Asn 193), the side chains of Lys 43 and Ser 194, and the main chain NH groups of Met 69, Gly 70, and Leu 71. Of these the Lys 43 side chain makes hydrogen bonds to both the flavin isoalloxazine ring and the carboxylate group of the orotate. Potential interactions with bound dihydroorotate are considered using the orotate complex as a basis for molecular modeling. The role of Cys 130 as the active site base is discussed, and the sequence conservation of the active site residues across the different families of DHODs is reviewed, along with implications for differences in substrate binding and in the catalytic mechanisms between these families.

[1]  D. Karibian Dihydroorotate dehydrogenase (Escherichia coli). , 1978, Methods in enzymology.

[2]  V. Hines,et al.  Mechanistic studies on the bovine liver mitochondrial dihydroorotate dehydrogenase using kinetic deuterium isotope effects. , 1989, Biochemistry.

[3]  K. Jensen,et al.  The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis. , 1997, Structure.

[4]  P. Cook,et al.  Acid base catalytic mechanism of the dihydropyrimidine dehydrogenase from pH studies. , 1993, The Journal of biological chemistry.

[5]  T. Spector,et al.  Inactivation of dihydropyrimidine dehydrogenase by 5-iodouracil. , 1991, The Journal of biological chemistry.

[6]  K. Jensen,et al.  Purification and characterization of dihydroorotate dehydrogenase a from lactococcus lactis, crystallization and preliminary X‐ray diffraction studies of the enzyme , 1996, Protein science : a publication of the Protein Society.

[7]  R. Read Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[8]  Jack Parker Davis,et al.  The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. , 1996, Biochemistry.

[9]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[10]  K. Jensen,et al.  Nucleotide sequence of the pyrD gene of Escherichia coli and characterization of the flavoprotein dihydroorotate dehydrogenase. , 1985, European journal of biochemistry.

[11]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[12]  P. Andersen,et al.  Two different dihydroorotate dehydrogenases in Lactococcus lactis , 1994, Journal of bacteriology.

[13]  R M Esnouf,et al.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.

[14]  K. Jensen,et al.  The B Form of Dihydroorotate Dehydrogenase from Lactococcus lactis Consists of Two Different Subunits, Encoded by the pyrDb and pyrK Genes, and Contains FMN, FAD, and [FeS] Redox Centers* , 1996, The Journal of Biological Chemistry.

[15]  P. Morand,et al.  Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound (*) , 1995, The Journal of Biological Chemistry.

[16]  B. Kirschbaum,et al.  Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme. , 1996, European journal of biochemistry.

[17]  K. Jensen,et al.  Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. , 1997, Biochemistry.

[18]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[19]  A. Katritzky,et al.  β-Ureido acids and dihydrouracils—VII , 1969 .

[20]  D. Morré,et al.  Structure-activity relationships of pyrimidines as dihydroorotate dehydrogenase inhibitors. , 1988, Biochemical pharmacology.

[21]  J. Koskikallio,et al.  The Crystal Structure of Ammonium Orotate Monohydrate. , 1971 .

[22]  F. S. Mathews,et al.  Spinach glycolate oxidase and yeast flavocytochrome b2 are structurally homologous and evolutionarily related enzymes with distinctly different function and flavin mononucleotide binding. , 1991, Journal of Biological Chemistry.

[23]  Frank,et al.  cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria. , 1994, The Journal of biological chemistry.

[24]  P. Andersen,et al.  Sequence analysis and identification of the pyrKDbF operon from Lactococcus lactis including a novel gene, pyrK, involved in pyrimidine biosynthesis , 1996, Journal of bacteriology.